Document is current
Any future updates will be listed below
-
Authors
Yu, Xiaodi https://orcid.org/0000-0001-7520-0646
Abeywickrema, Pravien
Bonneux, Brecht https://orcid.org/0000-0001-6869-8183
Behera, Ishani
Anson, Brandon
Jacoby, Edgar
Fung, Amy
Adhikary, Suraj
Bhaumik, Anusarka
Carbajo, Rodrigo J. https://orcid.org/0000-0002-0312-6499
De Bruyn, Suzanne https://orcid.org/0009-0004-9884-4929
Miller, Robyn
Patrick, Aaron
Pham, Quyen
Piassek, Madison
Verheyen, Nick
Shareef, Afzaal https://orcid.org/0000-0002-5621-8151
Sutto-Ortiz, Priscila
Ysebaert, Nina
Van Vlijmen, Herman
Jonckers, Tim H. M.
Herschke, Florence
McLellan, Jason S. https://orcid.org/0000-0003-3991-542X
Decroly, Etienne https://orcid.org/0000-0002-6046-024X
Fearns, Rachel https://orcid.org/0000-0003-0783-7498
Grosse, Sandrine
Roymans, Dirk
Sharma, Sujata
Rigaux, Peter
Jin, Zhinan https://orcid.org/0009-0009-7032-1460
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 11 October 2023
First Online: 21 October 2023
Competing interests
: The authors declare no competing interests. N.Y., S.D.B., M.P., N.V., A.F., I.B., B.A., Z.J., A.B., A.P., P.A. S.A. X.Y. R.J.C S.G., E.J. S.S., T.J., P.R., N.Y., D.R., and F.H. are employees and possible shareholders of Johnson & Johnson Innovative Medicine. R.F., P.S-O., E.D. and J.S.M. received research funding from Johnson & Johnson Innovative Medicine. During the manuscript preparation, R.F. has a sponsored research agreement with Merck & Co. B.B. is a graduate student from Antwerp University and has received funding from Johnson & Johnson Innovative Medicine and from the agency Flanders Innovation and Entrepreneurship (VLAIO) for this work.
